• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Nuuvera’s Shareholders Approve Arrangement Deal with Aphria

    Bryan Mc Govern
    Mar. 21, 2018 08:42AM PST
    Cannabis Investing News

    Nuuvera announced its special meeting of shareholders voted in favor of Aphria acquiring all of the issued and outstanding shares of Nuuvera not already owned by it.

    Nuuvera (TSXV:NUU) announced its special meeting of shareholders voted in favor of Aphria (TSX:APH; OTC:APHQF) acquiring all of the issued and outstanding shares of Nuuvera not already owned by it.

    As quoted in the press release:

    The Arrangement required approval by: (i) 66⅔ [percent] of the votes cast by shareholders present in person or represented by proxy at the Meeting; and (ii) a simple majority of the votes cast by shareholders present in person or represented by proxy at the Meeting, excluding the votes cast by such shareholders as are required to be excluded pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101“).

    A total of 60,129,430 Nuuvera shares, representing approximately 67.15 [percent] of the outstanding Nuuvera shares, were represented in person or by proxy at the Meeting. Of the votes cast with respect to the Arrangement, an aggregate of 60,073,288 Nuuvera shares were voted in favor of the Arrangement, representing approximately 99.90% of the votes cast on the resolution.  In addition, an aggregate of 47,193,288 Nuuvera shares, representing approximately 99.88 [percent] of the votes cast on the resolution excluding such shareholders as are required to be excluded pursuant to MI 61-101, were voted in favor of the Arrangement.

    Click here to read the full press release.

    Source: www.newswire.ca

    cannabis investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Numinus Wellness Inc. Announces Third Quarter Fiscal 2025 Results

    Numinus Wellness Inc. Announces Third Quarter Fiscal 2025 Results

    Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights

    Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    The Tinley Beverage Company

    TNY:CNX

    extractX

    Hygrovest Limited

    HGV:AU

    Lords & Company Worldwide Holdings

    LRDS:CNX
    Lords & Company Worldwide Holdings Logo

    Adastra Holdings

    XTRX:CNX

    MMJ Group Holdings

    MMJ:AU
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×